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Abstract 
Purpose: To evaluate the anti-obesity effects of five compounds isolated from Calophyllum andersonnii 
and Calophyllum sclerophyllum, viz, friedelin (CP1), friedelinol (CP2), isodispar B (CP3), 5,7-dihydroxy-
6-(3-methybutyryl)-4-phenylcoumarin (CP4) and 5,7-dihydroxy-6-(2-methybutyryl)-4-phenylcoumarin 
(CP5) in 3T3-L1 mouse pre-adipocytes. 
Methods: Maximum non-toxic doses (MNTDs) of CP1 - CP5 were obtained by conducting 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Intracellular lipid droplet 
accumulation was determined by Oil Red O (ORO) staining. The effects of CP1 - 5 on the expression of 
adipogenesis transcriptional factors, namely, C/ebpα, Pparγ1, aP2 and on cellular glucose uptake and 
adipokine (adiponectin, leptin, resistin) secretion were assessed by commercial colorimetric and ELISA 
kits, respectively.  
Results: MNTDs for CP1-CP5 were 3.0, 1.4, 1.0, 29.0 and 25.0 µM, respectively. 3T3-L1 cells treated 
with CP1 - CP3 showed increased lipid accumulation (p < 0.05) and decreased glucose uptake (p < 
0.05), compared with untreated cells; cells treated with CP4 and CP5 had opposite effects. Cells treated 
with CP4 and CP5 also showed downregulated Pparγ1, C/ebpα and aP2 expression (p < 0.05), 
compared with untreated cells. The anti-adipogenic property exerted by CP4 and CP5 manifested as 
increased secretion of adiponectin as well as reduced leptin and resistin levels.  
Conclusion: CP4 and CP5 isolated from Calophyllum sclerophyllum show promising anti-obesity 
properties, and could serve as candidate hits for further investigation at in vivo level to provide 
additional mechanistic evidence.   
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The genus Calophyllum, commonly known as 
“bintangor” or “penaga” in Malay, is a large group 
of tropical trees made up of around 200 different 
species [1]. Numerous Calophyllum species have 
been used in folk medicine. In Malaysia, the seed 
oil is used as a remedy for ulcer and rheumatism 
ailments. Moreover, Dweck and Meadows [2] 
reported the wound-healing property of 
Calophyllum seed oil after applying on scars. An 
infusion of the leaves is used to treat inflamed 
eyes.  
 
Further pharmacological research on this genus 
has further revealed a variety of biological 
activities exhibited by these plants, such as anti-
HIV, antibacterial, antimalarial, antioxidant, 
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antitumor-promoting, and cytotoxic activities [3]. 
These biological activities have been attributed to 
phytochemicals such as xanthones, coumarins, 
chomanones (flavonoids, biflavonoids), terpenes 
and steroids [3].  
 
Isolation of phytochemicals from Calophyllum 
andersonnii and Calophyllum sclerophyllum 
(native in the jungle of Landeh, Sarawak, Borneo 
Malaysia) yielded two classes, namely 




phytochemicals could have potential adipogenic 
modulatory effects, as previous studies have 
shown that friedelin and freidelinol isolated from 
other plants have pro-adipogenic effects [5,6] 
while esculetin, a coumarin, has anti-adipogenic 
effect [7,8].  
 
Therefore, the objective of this study was to 
investigate if the five triterpenoids and coumarins 
above would have the same pro-/anti-adipogenic 
effects on a differentiated mouse pre-adipocyte 
cell line, 3T3-L1. Adipogenic parameters 
assessed included intracelluar lipid droplet 
accumulation, glucose uptake, gene expression 
of adipogenic transcription factors and secretion 




Plant, isolation and characterization of 
compounds  
 
Triterpenoids - friedelin (compound 3) and 
friedelinol (compound 11) were isolated from 
Calophyllum andersonnii, while coumarins - 
isodispar B (compound 1), 5,7-Dihydroxy-6-(3-
methybutyryl)-4-phenylcoumarin (compound 2) 
and 5,7-Dihydroxy-6-(2-methybutyryl)-4-
phenylcoumarin] were isolated from Calophyllum 
sclerophyllum [4] The detailed steps involved in 
the isolation and characterization of the 
compounds used in this study are as described 
previously [4]. Figure 1 shows the structure, 





Mus musculus mouse fibroblast cell line 3T3-L1 
(ATCC® CL-173™) was obtained from the 
American Type Culture Collection (Manassas, 
VA, U.S.A.). Methods to differentiate 3T3-L1 pre-
adipocytes were achieved according to ATCC 
protocol. Seeded cells were maintained in pre-
adipocyte expansion medium [90 % Dulbelcco’s 
Modified Eagle’s Medium (DMEM; Thermo 
Fischer Scientific PA, USA),  
 
Figure 1: Structure, molecular weight (g/mol) and codes of five selected compounds used in this study 
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10 % Fetal Bovine Serum (FBS; Sigma-Aldrich, 
MO, USA)] by incubating them at 37 °C in a 5 % 
humidified CO2 incubator for 48 h until 100 % 
confluence was achieved (day 0). To induce 
differentiation, cells were incubated with 
differentiation medium [90 % DMEM, 10 % FBS, 
0.5 mM 3-isobutyl-1-methylxanthine (Merck 
KGaA, Germany), 0.25 µM dexamethasone 
(Merck KGaA, Germany), 1 µg/mL insulin 
(Nacalai Tesque, Japan) and 2 µM rosiglitazone 
(Nacalai Tesque, Japan)] for 72 h (day 3). Cells 
were then maintained in adipocyte maintenance 
medium (90 % DMEM, 10 % FBS and 1 µg/mL 
insulin) for another 2 d (day 5), which was 
subsequently changed every 2 d. At day 10, the 
cells were fully differentiated after induction and 
subsequent bioassays were performed.  
 
Determination of maximum non-toxic dose 
(MNTD)  
 
A total of 2500 3T3-L1 pre-adipocytes cells/well 
were plated in 96-well plates. At 70 % 
confluence, the cells were treated with the test 
compounds (0, 1.875, 3.75, 7.5, 15, 30 and 60 
µM), dissolved in dimethyl sulfoxide (DMSO). 
Cell viability was assessed by 3-(4,5-
dimethylthiazol-2-yl)-2.5-diphenyltetrazolium 
bromide (MTT) assay. The cells were incubated 
for 48 h at 37 ºC in humidified 5 % CO2. After 48 
h, cells were rinsed twice with phosphate buffer 
saline (PBS). Twenty microliters of 5 mg/mL MTT 
(Bio Basic Canada Inc, Canada) stock solution 
were added to each well, further incubated at 37 
ºC for 4 h, before the addition of 100 µL DMSO 
to solubilize the purple formazan crystals. After 1 
h of incubation, the absorbance was measured at 
570 nm using a microplate reader (M200 Tecan, 
Switzerland). A graph of percentage of toxicity 
against the log10 concentration of phytochemicals 
was plotted to determine the MNTD or ½ MNTD 
of the compounds. MNTD was determined at the 
first x-intercept where the toxicity is 0 %, while 
½MNTD was half of the MNTD selected. These 
dosages were then added together in the 
differentiation medium at day 0 of differentiation 
as described in ‘Cell Culture’. 
 
Determination of intracellular lipid droplet 
accumulation  
 
Eight days (day 10) after the induction of 
differentiation, the cells were rinsed three times 
with PBS. After fixation with paraformaldehyde 
(Sigma-Aldrich, MO, USA) for 1 h, the cells were 
rinsed with PBS and then stained with freshly 
diluted ORO solution [3 parts 0.5 % ORO (R&M 
Chemicals, UK) in isopropyl alcohol and 2 parts 
of water] for 30 min. The cells were then rinsed 
twice with water and visualized and 
photographed using an inverted phase contrast 
microscope (TS100, Nikon Eclipse, Japan). ORO 
stain was dissolved in isopropyl alcohol for 
quantitative analysis, and absorbance at 520 nm 
was measured using a microplate reader (M200, 
Tecan, Switzerland). 
 
Glucose uptake assay 
 
Glucose uptake was measured using glucose 
uptake assay kit (Abnova, Taiwan) according to 
manufacturer’s instructions. First, 3T3-L1 cells 
were plated in 96-well plate and differentiated, 
and at day 10 the differentiated cells were 
starved for 12 h without the addition of FBS to 
the basic medium. The cells were then treated 
with insulin (100 nM), metformin (1 mM; Sigma-
Aldrich, MO, USA), MNTDs of CP1-CP5 and 2-
deoxyglucose (2-DG) (negative control), for 1 h. 
Cellular 2-DG uptake was then measured by 
monitoring OD ratio increase at 570/610 using a 
microplate reader. The OD ratio for 2-DG 
(negative control) was normalised at 1000 µM. 
 
Measurement of adipokine concentration  
 
After treatments, conditioned media were 
collected and cells were then rinsed with ice-cold 
PBS twice and lysed with 10 µL of lysis buffer [10 
mM Tris/HCl, pH 7.8, 100 mM NaCl, 0.5 % (w/v) 
sodium deoxycholate, 0.05 % (v/v) nonidet-P40, 
10 mM EDTA, 0.1 mM PMSF] added with 1 µL of 
protein inhibitor cocktail (Thermo Fischer 
Scientific PA, USA). Subsequently, 
concentrations of mouse leptin, resistin and 
adiponectin in the conditioned medium and cell 
lysates were determined using commercial 
ELISA kits (CUSABIO, China) according to 
manufacturer’s instructions. Protein 
concentrations of media and cell lysates were 
also measured by bicinchoninic acid protein 
assay kit (Thermo Fischer Scientific PA, USA) 
and adipokine concentrations were normalized 
per total extracted proteins.  
 
Determination of gene expression of 
adipogenesis markers  
 
The gene expression of three common 
adipogenesis markers namely mouse nuclear 
receptor peroxisome proliferator-activated 
receptor gamma 1 (Pparγ1), CCAAT/enhancer 
binding protein-alpha (C/ebpα), and adipocyte 
fatty acid-binding protein (aP2) was assessed by 
semi-quantitative reverse transcription-
polymerase chain reaction (RT-PCR). Total RNA 
was extracted from the 3T3-L1 adipocyte cells 
using EZ 10 Spin Column animal total RNA 
extraction kit (Bio Basic Canada Inc., Canada) 
according to manufacturer’s instructions. RNA 
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purity and concentration were determined using 
a nanospectrophotometer (IMPLEM, Germany) 
at absorbance of 260 and 280 nm. The integrity 
of total RNA extracted was assessed by using 1 
%(w/v) agarose gel electrophoresis and 
denaturing agent formamide. The primer 
sequences for RT-PCR were adopted from [8,9]. 
RT-PCR was performed using Realhelix™ RT-
PCR Kit (Nanohelix, Korea) according to 
manufacturer’s instructions on Bio-Rad CFX-96T 
RT-PCR machine following this protocol: 1 cycle 
of cDNA synthesis at 55 °C for 50 min; 1 cycle of 
initial-denaturation at 95 °C for 15 min; 30 cycles 
of denaturation at 95 °C for 20 s, annealing at 
53, 57, 57 and 62°C for C/ebpα, Pparγ1, aP2, β-
actin, respectively, for 40 s and extension at 72 
°C for 40 s and a final cycle of post extension at 
72 °C for 5 min. PCR products were resolved by 
1.8 % agarose gel electrophoresis, stained with 
Gel Red® dye (Biotium, CA, USA) and visualized 
with BIO-RAD Gel Doc image analysis software 
(BIO-RAD Laboratories Inc., CA, USA). 





The results are expressed as mean ± standard 
error of the mean (SEM) of at least two 
independent experiments performed in at least 
triplicate, unless otherwise stated. Statistical 
analysis was performed using Student’s t-test for 
comparison between two means using IBM 
SPSS Statistics software version 16.0 (IBM, NY, 





MNTD and ½ MNTD of the compounds 
 
In the graph of cytotoxicity percentage in 3T3-L1 
pre-adipocytes against log CP1-CP5 
concentrations (Figure 2), the percentage of 
cytotoxicity for CP1, CP2 and CP5 showed 
fluctuations across concentrations while the 
percentage of cytotoxicity for CP3 and CP4 
showed an increasing trend across 
concentrations.. However, cell death was not 
evident at concentrations below 3.75 µM, for 
CP1 and CP2; and at concentrations below 30 
µM for CP3 and CP4 (Figure 2). MNTDs of CP1, 
CP2, CP3, CP4 and CP5 were 3.00, 1.44, 1.04, 
29.0 and 25.0 µM, respectively, while their 
½MNTDs were 1.50, 0.72, 0.52, 14.5 and 12.5 
µM, respectively. Overall, cytotoxicity of CP3 was 
the highest, and triterpenoids CP1 and CP2 were 
up to 20-folds more cytotoxic than 
phenylcoumarins CP4 and CP5.  
Phenylcoumarins inhibit intracellular lipid 
accumulation  
 
As an evidence of adipogenesis, copious ORO 
dye stained material accumulated in 
differentiated 3T3-L1 adipocytes (positive 
control) while no staining was detected in 3T3-L1 
preadipocytes (negative control, Figure 3A). 
Compared to the negative control, cells treated 
with MNTDs and ½ MNTDs of CP1 - CP3 
showed higher accumulation of dye-stained 
material; CP4 and CP5 showed opposite effects 
(Figure 3A). A 100× magnification of the cells 
revealed larger adipocytes for CP1 - CP3 
(indicating higher lipid droplet accumulation), 
while the opposite was observed for CP4 - CP5 
(Figure 3B). 
 
As shown in Figure 3C and D, there was almost 
50 % less lipid accumulation in non-differentiated 
3T3-L1 cells compared with differentiated cells. 
CP2 and CP3 at both doses significantly 
increased lipid accumulation compared with the 
positive control, while CP4 and CP5 at both 
doses decreased lipid accumulation of up to 0.7-
fold, albeit with statistical significance for the 
latter compound. Taken together, this implies 
that CP4 and CP5 would indeed attenuate 
adipocyte differentiation.  
 
Phenylcoumarins promote cellular glucose 
uptake in 3T3-L1 adipocytes  
 
As shown in Figure 4, treatment with insulin and 
with insulin + metformin (a type II diabetes 
mellitus drug) significantly increased cellular 
uptake of glucose in 3T3-L1 adipocytes. 
Treatment with MNTDs of CP1, CP2 and CP3 
significantly decreased cellular glucose uptake 
compared with insulin-treated cells. On the other 
hand, CP4 and CP5 significantly stimulated 
cellular glucose uptake compared with insulin-
treated cells, but still the amount was still lesser 
than the synergistic effect of insulin + metformin 
(Figure 4). These indicate that phenylcoumarins 
CP4 and CP5 promote cellular glucose uptake in 
3T3-L1 adipocytes, comparable with the effect of 
insulin. 
 
Phenylcoumarins inhibit adipogenesis by 
reducing gene expression of C/ebpα, Pparγ1 
and aP2  
 
As shown in Figure 5, cells treated with CP1, 
CP2 and CP3 presented significant increases in 
the expression of adipocyte-specific 
transcriptional factors when compared with the 
untreated cells. 
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Specifically, cells treated with CP2 had the 
highest expression of C/ebpα and Pparγ1. 
Adipocyte specific transcriptional factor, aP2 
showed the highest expression when cells were 
treated with CP1, which was about 18 % higher 
compared to the control (Figure 5). On the other 
hand, cells treated with CP4 and CP5 showed 
significant down-regulation of the expression of 
all three adipogenesis markers (Figure 5), 
implying that CP4 and CP5 attenuate adipocyte 
differentiation. 
 
Phenylcoumarins from increase adiponectin 
and leptin secretion and decrease resistin 
secretion  
 
As shown in Figure 6, differentiated 3T3-L1 
adipocytes had increased secretions of 
adiponectin, leptin and resistin compared with 
undifferentiated pre-adipocytes. Cells treated 
with ½MNTD CP5 had the highest amount of 
adiponectin secretion in conditioned medium, 
consistent with the lowest amount of intracellular 
adiponectin (Figure. 6A). Leptin secretion in 
conditioned medium was the highest in cells 
treated with CP2 (½MNTD), while the same cells 
had among the lowest intracellular leptin 
concentration (Figure 6B). Cells treated with CP4 
had the highest intracellular leptin concentration. 
As for resistin, cells treated with CP3 (½MNTD) 
had the highest secretion (2.5 times higher) 
compared with differentiated adipocytes, while 
the lowest for cells treated with CP5 (MNTD) 
(Figure 6C). For intracellular resistin 
concentration, cells treated with CP1 (MNTD) 
 
 
Figure 2: Maximum non-toxic dose (MNTD) and half maximum non-toxic dose (½ MNTD) of CP1 - CP5. 
Percentage of cytotoxicity of A. CP1; B. CP2; C. CP3; D. CP4; and E. CP4 on 3T3-L1 pre-adipocytes after 
incubation for 48 h, in two-fold dilution method with the range of 60 µM to 0 µM. MNTDs were determined where 
the graph intersects the x-axis, while ½MNTDs are half of the MNTDs obtained. Data are mean ± SEM of three 
independent experiments performed in five replicates 
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Figure 3: Intracellular lipid droplet accumulation in 3T3-L1 adipocytes. A = representative images after induction 
of differentiation with the differentiation cocktail along with the MNTDs and ½ MNTDs of CP1 - CP5. Red colour 
indicates ORO staining; the darker the stain, the higher the intracellular lipid droplet content. The amount of lipid 
accumulation were compared using the well of 3T3-L1 adipocytes (positive control); B = Representative fields 
with 100× magnification of the wells in A for CP1 - CP5, showing the sizes of the adipocytes; C = % of lipid 
accumulation in 3T3-L1 treated cells and controls; D = Fold increases of lipid accumulation in 3T3-L1 treated 
cells and controls. Results are presented as mean ± SEM (n = 3); *p < 0.05; **p < 0.01 compared with 3T3-L1 
adipocytes; #p < 0.05; ##p < 0.01 compared to 3T3-L1 pre-adipocyte 
 
 
Figure 4: Effect of compounds CP1 - CP5 on cellular glucose uptake in 3T3-L1 adipocytes. Results are 
presented as mean ± SEM, (n = 3); *p < 0.05 compared with the negative control; #p < 0.05 compared with 
insulin-treated cells (positive control) 
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Figure 5: Effect of compounds CP1-CP5 on the expression of adipogenesis markers C/ebpα, Pparγ1 and aP2 in 
3T3-L1 adipocytes. Total RNA was extracted from differentiated 3T3-L1 adipocytes treated with MNTDs of CP1-
CP5 compounds and semi quantitative RT-PCR was performed for gene expression of A. C/ebpα; B. Pparγ1 and 
C. aP2. Bar charts depict the densitometry as expressed as relative pixel density and expressed as ratio to β-
actin (internal control not affected by compound treatment). Data are expressed as a percentage of control (set 
as 100 %) and values represent mean ± SEM (n = 3) of three independent experiments; *p < 0.05; **p <0.01 
compared to the control 
 
Figure 6: Extracellular secretions and intracellular concentrations of adiponectin, leptin and resistin treated or 
untreated with ½MNTD and MNTDs of CP1-CP5. Measurements of concentrations for A. Adiponectin; B. Leptin; 
C. Resistin, were conducted using commercial ELISA kits. Absorbance measurements were normalized per total 
extracted proteins. Data are expressed as concentration (pg/mL)/µg protein and values represent the mean ± 
SEM (n = 3) of three independent experiments; *p < 0.05, **p < 0.01 compared to 3T3-L1 adipocytes 
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showed 6.5 times higher level compared with 




Previously, it was shown that friedelin, a 
triterpenoid isolated from Garcinia prainiana, 
upregulated adipocyte differentiation and glucose 
uptake in 3T3-L1 adipocytes [6], while esculetin 
(a coumarin derivative), either naturally isolated 
from Fraxinus rhynchophylla [7] or chemically-
synthesized [8], has anti-adipogenic effect. In this 
study, we found that the anti-adipogenic and pro-
glucose uptake activities of CP4 and CP5 are 
consistent with the reduced expression of 
adipogenesis markers Pparγ1, C/ebpα, aP2, 
increased secretion of adiponectin and reduced 
secretion of leptin and resistin. 
 
It is widely reported that adipogenesis can be 
inhibited or promoted by various natural 
compounds [6-8]. Two out of three coumarins 
that showed anti-adipogenic activity are CP4 and 
CP5. Isodipar B (CP3), also a coumarin, however 
showed pro-adipogenic effect. This may be due 
to the structural differences within the coumarins, 
as reported in [7]. There were differences in the 
moiety of R-group added to coumarin, the 
backbone of the phytochemicals [6,10]. 
 
Methylbutyryl located on a different carbon might 
cause a difference in activity in adipocytes. In 
CP3, the R-group is located in C-8 of the 
coumarin backbone. These results therefore, 
suggest that methylbutyryl located in C-8 is 
important for exerting anti-adipogenic effect. For 
cells treated with CP1 and CP2, an induction in 
lipid accumulation was observed. Friedelin 
naturally isolated from Garcinia prainiana also 
exerted the same activity [6], albeit at a higher 
concentration of 10 μM (vs. 3 μM in our study).  
 
Unlike friedelin from Garcinia prainiana which 
promoted cellular glucose uptake in 3T3-L1 
adipocytes [6], our results showed the opposite 
effect. This discrepancy could be due to the 
higher dose used in our study. For the first time, 
we observed that treatment with CP4 and CP5 
promoted 3T3-L1 adipocyte uptake of glucose, to 
the extent that it was even significantly higher 
than the positive control, insulin. Therefore, 
compounds CP4 and CP5 may imitate the action 
of insulin in stimulating cellular glucose uptake 
and it is speculated that these compounds may 
also reduce blood glucose level in vivo. Based on 
the above findings, it appears that our findings 
related to the effect of phenylcoumarins CP4 and 
CP5 on 3T3-L1 adipocytes were in agreement 
with two other reports [12,13] stating that 
compound that inhibits adipocyte differentiation 
could also improve glucose uptake.  
 
In this study, we also measured the gene 
expression of three common adipogenesis 
markers C/ebpα, Pparγ1 and aP2 to see if their 
expression correlates with the adipocyte 
differention/lipid droplet accumulation as 
assessed by ORO staining. C/ebpα and Pparγ 
activate transcriptional adipogenesis activity by 
binding to their genomic promoter region 
interchangeably [14]. Cells treated with CP1, 
CP2 and CP3 showed pro-adipogenic activity, by 
increasing Pparγ1, C/ebpα and aP2 expression. 
Conversely, CP4- and CP5-treated cells showed 
a reduction in the expression of Pparγ1, C/ebpα 
and aP2. The findings are supported by previous 
studies which showed that the reduction in 
adipocyte differentiation and increase in cellular 
glucose uptake are also correlated with the 
downregulation of C/ebpα, Pparγ1 and aP2 
expression [8,15].  
 
Besides playing a role as an energy depot, the 
adipose tissue also secretes adipokines that are 
metabolic regulators. Three adipokines assessed 
in this study – adiponectin, leptin and resistin, 
modulate adipogenesis and are correlated with 
body mass index and total body fat [16]).  
Plasma levels of leptin and resistin has been 
shown to be proportional to body fat mass 
[17,18], whereas plasma adiponectin level is 
negatively correlated with the percentage of body 
fat [19]. Therefore, we hypothesized that CP4 
and CP5 compounds which show anti-
adipogenic/pro-glucose uptake effects would also 
show increased adiponectin and decreased 
leptin and resistin secretions in 3T3-L1 
adipocytes. However, we found that CP1 - CP4 
(MNTD) compounds produced mixed effects on 
the secretions of these adipokines, which do not 
correlate with their adipogenic/glucose uptake 
properties shown earlier. This phenomenon 
could be due to the unassessed complex 
signaling pathways that modulate the secretion 
of these adipokines and adipogenesis/glucose 
uptake independently. Nevertheless, CP5 
(MNTD) consistently produced increased 
adiponectin and reduced leptin and resistin 
secretions, compared with untreated cells. 
Similarly, ginsenoside has been shown to reduce 
3T3-L1 adipocyte lipid accumulation and 
increase adiponectin expression [20], while 
Lysimachia foenum-graecum treatment 
increased adiponectin level while decreasing 
leptin and resistin levels in the plasma of treated 
mice [21].  
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Friedelin and friedelinol isolated from 
Calophyllum andersonnii promote adipogenesis 
by increasing intracellular lipid droplet 
accumulation and expression of adipogenesis-
related genes including Pparγ1, C/ebpα and aP2, 
and also by decreasing cellular glucose uptake in 
3T3-L1 adipocytes. On the other hand, 5,7-
dihydroxy-6-(3-methybutyryl)-4-phenylcoumarin 
and 5,7-dihydroxy-6-(2-methybutyryl)-4-phenyl-
coumarin isolated from Calophyllum 
sclerophyllum show promising anti-obesity 
properties by attenuating adipogenesis 
(decreasing intracellular lipid droplet 
accumulation and expression of Pparγ1, C/ebpα 
and aP2), and also by increasing 3T3-L1 
adipocyte glucose uptake. Last but not least, 5,7-
dihydroxy-6-(2-methybutyryl)-4-phenylcoumarin 
increases adiponectin and reduces leptin and 
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